Clinical trials for Indolent systemic mastocytosis
5 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07255638A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in GermanyBlueprint Medicines Corporation
- ACTIVE NOT RECRUITINGPhase 2NCT05186753(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisCogent Biosciences, Inc. · PI: Rachael Easton, MD, PhD
- RECRUITINGPHASE2, PHASE3NCT04910685(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisBlueprint Medicines Corporation
- RECRUITINGPhase 2NCT04655118Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic MastocytosisTelios Pharma, Inc.
- ACTIVE NOT RECRUITINGPhase 2NCT03731260(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic MastocytosisBlueprint Medicines Corporation